Skip to end of banner
Go to start of banner

Antibody Epitope Nomenclature Style

Skip to end of metadata
Go to start of metadata

You are viewing an old version of this page. View the current version.

Compare with Current View Page History

« Previous Version 3 Current »

In order to ensure a consistent nomenclature for antibody targets we request that you use the following nomenclature:

  • epitope should be formatted using the following style:

    • if phospho-specific, have the prefix “phospho-” followed by

    • gene symbol/protein symbol e.g. “NF2” followed by

    • if phospho-specific, should label the phospho-target in parentheses with the three-character amino acid (aa) abbreviation followed by the location e.g. “(Ser2515)” followed by

    • if mutation-specific, should label the protein variant using one-character aa abbreviation eg. “(G12V)” followed by

    • if available, aa location of target in parentheses in the format of (aa START-END) e.g. “(aa 100-150)” or “(aa 507-530 N-term)”

    • examples of valid epitopes:

      • NF1

      • phospho-NF1 (Ser2515)

      • KRAS (G12V)

      • NF1 (aa 100-150)

      • NF1 (aa 507-530 N-term)

If you have an epitope that for does not fit in this nomenclature, let us know (Contact Us ) and we’d be happy to work with you to extend the nomenclature to fit your needs.

  • No labels